Advanced-Stage Hodgkin Lymphoma

The Lymphoma Research Foundation formed a multidisciplinary consortium dedicated to advancing and harmonizing treatment for adolescents and young adults with lymphoma.

In this video, Stephen M. Ansell, MD, PhD, discussed updated study results showing an advantage of nivolumab-chemo over brentuximab vedotin-chemo in both younger and older patients.

In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition.